168 related articles for article (PubMed ID: 34244231)
1. Potentiation of Muscarinic M
Okimoto R; Ino K; Ishizu K; Takamatsu H; Sakamoto K; Yuyama H; Fuji H; Someya A; Ohtake A; Ishigami T; Masuda N; Takeda M; Kajioka S; Yoshimura N
J Pharmacol Exp Ther; 2021 Oct; 379(1):64-73. PubMed ID: 34244231
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic M
Okimoto R; Ino K; Ishizu K; Takamatsu H; Sakamoto K; Yuyama H; Imazumi K; Ohtake A; Masuda N; Takeda M
Low Urin Tract Symptoms; 2022 Jul; 14(4):289-300. PubMed ID: 35150075
[TBL] [Abstract][Full Text] [Related]
3. Probing the binding site of novel selective positive allosteric modulators at the M
Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
[TBL] [Abstract][Full Text] [Related]
4. Dronedarone Modulates M1 and M3 Muscarinic Receptors with Subtype Selectivity, Functional Selectivity, and Probe Dependence.
Jayasuriya GM; Elmslie G; Burstein ES; Ellis J
Pharmacology; 2017; 99(3-4):128-138. PubMed ID: 27992867
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
[TBL] [Abstract][Full Text] [Related]
6. Discovery and structure-activity relationships study of positive allosteric modulators of the M
Tanaka H; Negoro K; Koike T; Tsukamoto I; Yokoyama K; Maeda J; Inagaki Y; Shimoshige Y; Ino K; Ishizu K; Takahashi T
Bioorg Med Chem; 2020 Jul; 28(13):115531. PubMed ID: 32386953
[TBL] [Abstract][Full Text] [Related]
7. Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.
Jakubík J; Randáková A; El-Fakahany EE; Dolezal V
BMC Pharmacol; 2009 Dec; 9():15. PubMed ID: 20038295
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.
Marlo JE; Niswender CM; Days EL; Bridges TM; Xiang Y; Rodriguez AL; Shirey JK; Brady AE; Nalywajko T; Luo Q; Austin CA; Williams MB; Kim K; Williams R; Orton D; Brown HA; Lindsley CW; Weaver CD; Conn PJ
Mol Pharmacol; 2009 Mar; 75(3):577-88. PubMed ID: 19047481
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of β-cell M
Zhu L; Rossi M; Cohen A; Pham J; Zheng H; Dattaroy D; Mukaibo T; Melvin JE; Langel JL; Hattar S; Matschinsky FM; Appella DH; Doliba NM; Wess J
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18684-18690. PubMed ID: 31451647
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Structure-Activity Relationships Study of N-Pyrimidyl/Pyridyl-2-thiazolamine Analogues as Novel Positive Allosteric Modulators of M
Tanaka H; Akaiwa M; Negoro K; Kawaminami E; Mihara H; Fuji H; Okimoto R; Ino K; Ishizu K; Takahashi T
Chem Pharm Bull (Tokyo); 2021; 69(4):360-373. PubMed ID: 33790081
[TBL] [Abstract][Full Text] [Related]
11. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.
Lazareno S; Birdsall B; Fukazawa T; Gharagozloo P; Hashimoto T; Kuwano H; Popham A; Sugimoto M; Birdsall NJ
Life Sci; 1999; 64(6-7):519-26. PubMed ID: 10069518
[TBL] [Abstract][Full Text] [Related]
12. Determination of Region-Specific Roles of the M
Igarashi-Hisayoshi Y; Ihara E; Bai X; Higashi C; Ikeda H; Tanaka Y; Hirano M; Ogino H; Chinen T; Taguchi Y; Ogawa Y
Dig Dis Sci; 2023 Feb; 68(2):439-450. PubMed ID: 35947306
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
[TBL] [Abstract][Full Text] [Related]
14. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A
Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343
[TBL] [Abstract][Full Text] [Related]
16. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder.
Braverman AS; Tibb AS; Ruggieri MR
J Pharmacol Exp Ther; 2006 Feb; 316(2):869-74. PubMed ID: 16243961
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic-3-receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial.
van Till JWO; Arita E; Kuroishi K; Croy R; Oelke M; van Koeveringe GA; Chapple CR; Yamaguchi O; Abrams P
Neurourol Urodyn; 2022 Jun; 41(5):1139-1148. PubMed ID: 35419807
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
Thomas RL; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
[TBL] [Abstract][Full Text] [Related]
19. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
20. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. II. Denervated rat bladder.
Braverman AS; Doumanian LR; Ruggieri MR
J Pharmacol Exp Ther; 2006 Feb; 316(2):875-80. PubMed ID: 16243962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
